SYM Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$605K Buy
4,057
+592
+17% +$83.1K 0.05% 137
2026
Q2
$438K Sell
3,465
-85
-2% -$11.2K 0.04% 175
2026
Q1
$495K Buy
3,550
+166
+5% +$23.2K 0.05% 132
2025
Q4
$415K Buy
3,384
+144
+4% +$17.5K 0.04% 156
2025
Q3
$360K Buy
3,240
+23
+0.7% +$2.61K 0.04% 172
2025
Q2
$357K Buy
3,217
+1,318
+69% +$140K 0.04% 172
2025
Q1
$213K Buy
+1,899
New +$196K 0.03% 251

Other funds holding GILD

SYM Financial's GILD Position: Q3 2026 in Review

SYM Financial increased its Gilead Sciences (GILD) stake by 17% in Q3 2026, buying an estimated $83.1K and bringing the position to 4,057 shares worth $605K. The position accounts for 0.05% of the portfolio, ranked #137.

SYM Financial first reported a position in GILD in Q1 2025 and has held it in 7 quarters since. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • SYM Financial held 4,057 shares of Gilead Sciences worth $605K as of Q3 2026.
  • SYM Financial bought 592 Gilead Sciences shares in Q3 2026, an estimated $83.1K.
  • Gilead Sciences made up 0.05% of SYM Financial's portfolio in Q3 2026, its #137 holding.
  • SYM Financial first reported a position in Gilead Sciences in Q1 2025 and has held it in 7 quarters since.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on SYM Financial's 13F filing for Q3 2026, filed 26 Oct 2026.